VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 101 filers reported holding VERVE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,429,497 | -30.6% | 2,147,243 | -1.8% | 0.34% | -21.1% |
| Q2 2023 | $40,941,102 | +83.0% | 2,185,857 | +36.8% | 0.43% | +67.1% |
| Q1 2023 | $22,371,916 | -5.9% | 1,597,994 | +30.1% | 0.26% | -24.6% |
| Q4 2022 | $23,770,449 | -2.6% | 1,228,447 | +58.4% | 0.34% | +9.6% |
| Q3 2022 | $24,396,000 | +1542.8% | 775,697 | +573.2% | 0.31% | +1633.3% |
| Q2 2022 | $1,485,000 | +12.3% | 115,232 | +74.3% | 0.02% | +80.0% |
| Q1 2022 | $1,322,000 | -41.9% | 66,109 | -6.8% | 0.01% | -16.7% |
| Q4 2021 | $2,274,000 | -37.0% | 70,950 | -9.5% | 0.01% | -20.0% |
| Q3 2021 | $3,607,000 | – | 78,421 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $661,184,000 | 13.47% |
| Casdin Capital, LLC | 3,038,167 | $183,050,000 | 4.65% |
| Logos Global Management LP | 758,265 | $45,685,000 | 3.84% |
| Novo Holdings A/S | 793,265 | $47,794,000 | 2.12% |
| Redmile Group, LLC | 1,936,530 | $116,676,000 | 1.73% |
| Cormorant Asset Management, LP | 709,224 | $40,594,000 | 1.38% |
| Rock Springs Capital Management LP | 962,826 | $58,011,000 | 1.15% |
| Asymmetry Capital Management, L.P. | 24,790 | $1,494,000 | 1.03% |
| Darwin Global Management, Ltd. | 103,013 | $6,207,000 | 1.00% |
| RA Capital Management | 880,284 | $53,037,000 | 0.85% |